Back to "Incretin-based therapy did not increase ..."
Strong Support
causal
Analysis v1
History

Medications that target incretin hormones do not raise the likelihood of low blood sugar or pancreatitis in adults who are overweight or obese.

47
Pro
0
Against

Evidence from Studies

Supporting (1)

47

Community contributions welcome

47

Effect of Incretin-Based Therapies on Blood Pressure: A Systematic Review and Meta-Analysis.

Systematic Review With Meta-Analysis
Human
2026 May 15

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

Effect of Incretin-Based Therapies on Blood Pressure: A Systematic Review and Meta-Analysis.

Score: 47
DOI: 10.1093/eurjpc/zwaf560

Similar Assertions

Adults with overweight or obesity who take incretin-based therapies have a lower risk of dying from any cause compared to those who do not, based on combined data from multiple studies.

47
0
84%

Medications that target incretin hormones lower the risk of illness and death in people with diabetes by improving how the body processes glucose and functions of the heart and blood vessels.

0
0
74%